Mishra Dilip Kumar, Agrawal Madhu Sudan
Department of Urology, Global Rainbow Healthcare, Agra, India.
Department of Urology, Global Rainbow Healthcare, Agra, India.
Urology. 2017 May;103:59-62. doi: 10.1016/j.urology.2017.01.009. Epub 2017 Jan 16.
To assess the feasibility and safety of a novel flexible mini-nephroscope in minimally invasive percutaneous nephrolithotomy (PCNL). Presumably, limiting the size and number of tracts during PCNL has the potential of decreasing the morbidity of the procedure. We present our experience with this new technique.
A retrospective analysis of patients with multiple kidney stones treated with mini-PCNL combined with a novel flexible mini-nephroscope was performed. Minimally invasive PCNL was done with rigid 12 F MIP-M nephroscope, followed by flexible mini-nephroscopy for smaller stones in other inaccessible calyces. Record was made of the operating time, stone-free rates, postoperative pain, morbidity, hospital stay, time to recovery, complication rates, and ancillary procedures. Matched-pair analysis was done with cases operated by flexible ureteroscopy performed with Flex X-2 or Flex X-c scope.
Twenty-five patients in the study group were matched with 25 cases from the flexible ureteroscopy group. Both groups were comparable in terms of age, laterality, and mean composite stone burden. The mean operating time was 40.1 ± 10.6 minutes in the mini-PCNL group and 51.2 ± 8.8 minutes in the flexible ureteroscopy group. Mean hospital stay was similar in both groups. The primary stone clearance rate of 92% (23 of 25) in the mini-PCNL group was better than the clearance rate of 80% (20 of 25) in the flexible ureteroscopy group. Eight percent in the mini-PCNL group required ancillary procedures as compared with 20% of cases in the flexible ureteroscopy group. Postoperative pain and analgesia requirement in these patients was minimal. There were no significant complications.
Flexible mini-nephroscope is an effective adjuvant to minimally invasive PCNL in achieving high clearance rate with minimum morbidity.
评估一种新型柔性微型肾镜在微创经皮肾镜取石术(PCNL)中的可行性和安全性。据推测,在PCNL过程中限制通道的大小和数量有可能降低该手术的发病率。我们介绍我们在这项新技术方面的经验。
对采用微型PCNL联合新型柔性微型肾镜治疗的多发性肾结石患者进行回顾性分析。使用刚性12F MIP-M肾镜进行微创PCNL,随后使用柔性微型肾镜处理其他难以到达的肾盏中的较小结石。记录手术时间、结石清除率、术后疼痛、发病率、住院时间、恢复时间、并发症发生率和辅助手术情况。对使用Flex X-2或Flex X-c输尿管软镜进行手术的病例进行配对分析。
研究组的25例患者与输尿管软镜组的25例病例配对。两组在年龄、患侧和平均复合结石负荷方面具有可比性。微型PCNL组的平均手术时间为40.1±10.6分钟,输尿管软镜组为51.2±8.8分钟。两组的平均住院时间相似。微型PCNL组的初次结石清除率为92%(25例中的23例),优于输尿管软镜组的80%(25例中的20例)。微型PCNL组8%的患者需要辅助手术,而输尿管软镜组为20%。这些患者术后疼痛和镇痛需求极小。无明显并发症。
柔性微型肾镜是微创PCNL的一种有效辅助手段,可实现高清除率且发病率最低。